Login to Your Account

Synta Pharmaceuticals Corp.

Formerly STA-4783; a small molecule designed to increase the oxidative stress level in cancer cells to the point at which they undergo apoptosis

To continue reading subscribe now to BioWorld Phase III Report

Learn More about BioWorld Phase III Report

Already a subscriber? Sign In or Buy now to activate your subscription